Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Magenta Therapeutics and Heidelberg Pharma Team Up for Bone Marrow Transplants March 5, 2018 Roche Gets in on Bay Area Allakos' $100M Funding Round December 12, 2017 PE Firm in Talks to Buy VWR in Deal Worth $5 Billion May 3, 2017